A citation-based method for searching scientific literature

Sang Bum Kang, Ronald R Marchelletta, Harrison Penrose, Michael J Docherty, Declan F McCole. Pharmacol Res Perspect 2015
Times Cited: 6







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit.
Robert W Busby, Alexander P Bryant, Wilmin P Bartolini, Etchell A Cordero, Gerhard Hannig, Marco M Kessler, Shalina Mahajan-Miklos, Christine M Pierce, Robert M Solinga, Li Jing Sun,[...]. Eur J Pharmacol 2010
141
50

Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator.
Marcel J C Bijvelds, Alice G M Bot, Johanna C Escher, Hugo R De Jonge. Gastroenterology 2009
99
33

Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects.
Seth Sweetser, Irene A Busciglio, Michael Camilleri, Adil E Bharucha, Lawrence A Szarka, Athanasios Papathanasopoulos, Duane D Burton, Deborah J Eckert, Alan R Zinsmeister. Am J Physiol Gastrointest Liver Physiol 2009
57
33








Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents.
John Cuppoletti, Jayati Chakrabarti, Kirti P Tewari, Danuta H Malinowska. Am J Physiol Cell Physiol 2014
23
16

Effects of luminal thymol on epithelial transport in human and rat colon.
Izumi Kaji, Shin-ichiro Karaki, Atsukazu Kuwahara. Am J Physiol Gastrointest Liver Physiol 2011
29
16

Secretory effects of a luminal bitter tastant and expressions of bitter taste receptors, T2Rs, in the human and rat large intestine.
Izumi Kaji, Shin-ichiro Karaki, Yasuyuki Fukami, Masaki Terasaki, Atsukazu Kuwahara. Am J Physiol Gastrointest Liver Physiol 2009
75
16


Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
Viola Andresen, Michael Camilleri, Irene A Busciglio, April Grudell, Duane Burton, Sanna McKinzie, Amy Foxx-Orenstein, Caroline B Kurtz, Vineeta Sharma, Jeffrey M Johnston,[...]. Gastroenterology 2007
175
16

The laxative effect of bisacodyl is attributable to decreased aquaporin-3 expression in the colon induced by increased PGE2 secretion from macrophages.
Nobutomo Ikarashi, Kohta Baba, Takashi Ushiki, Risako Kon, Ayako Mimura, Takahiro Toda, Makoto Ishii, Wataru Ochiai, Kiyoshi Sugiyama. Am J Physiol Gastrointest Liver Physiol 2011
53
16




Is bisacodyl absorbed at all from suppositories in man?
E Flig, T W Hermann, M Zabel. Int J Pharm 2000
16
16

Substance P-evoked Cl(-) secretion in guinea pig distal colonic epithelia: interaction with PGE(2).
Yutaka Hosoda, Shin-Ichiro Karaki, Yukiko Shimoda, Atsukazu Kuwahara. Am J Physiol Gastrointest Liver Physiol 2002
18
16

Sodium caprate as an enhancer of macromolecule permeation across tricellular tight junctions of intestinal cells.
Susanne M Krug, Maren Amasheh, Isabel Dittmann, Ilya Christoffel, Michael Fromm, Salah Amasheh. Biomaterials 2013
97
16

Improving drug biological effects by encapsulation into polymeric nanocapsules.
Luiza A Frank, Renata V Contri, Ruy C R Beck, Adriana R Pohlmann, Silvia S Guterres. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2015
65
16

Challenges in the delivery of peptide drugs: an industry perspective.
Andrew L Lewis, Joël Richard. Ther Deliv 2015
34
16

Development and in vivo evaluation of an oral drug delivery system for paclitaxel.
Javed Iqbal, Federica Sarti, Glen Perera, Andreas Bernkop-Schnürch. Biomaterials 2011
44
16

Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice.
Nanthakumar Thirunarayanan, Eshel A Nir, Bruce M Raaka, Marvin C Gershengorn. Neuropsychopharmacology 2013
18
16

Colonic drug delivery.
Abraham Rubinstein. Drug Discov Today Technol 2005
34
16

Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit.
Teysir Halaby, Nashwan Al Naiemi, Jan Kluytmans, Job van der Palen, Christina M J E Vandenbroucke-Grauls. Antimicrob Agents Chemother 2013
113
16


The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo.
Ho-Ngoc Nguyen, Shiaw-Pyng Wey, Jyuhn-Huarng Juang, Kiran Sonaje, Yi-Cheng Ho, Er-Yuan Chuang, Chia-Wei Hsu, Tzu-Chen Yen, Kun-Ju Lin, Hsing-Wen Sung. Biomaterials 2011
70
16

A novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms.
Shmuel Tuvia, Dori Pelled, Karen Marom, Paul Salama, Maya Levin-Arama, Irina Karmeli, Gregory H Idelson, Isaac Landau, Roni Mamluk. Pharm Res 2014
55
16

Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation.
W Blair Geho, Hans C Geho, John R Lau, Theophilus J Gana. J Diabetes Sci Technol 2009
48
16


Significance of microflora in proteolysis in the colon.
S A Gibson, C McFarlan, S Hay, G T MacFarlane. Appl Environ Microbiol 1989
75
16

Time-action profile of an oral enteric insulin formulation in healthy Chinese volunteers.
Jiaqi Li, Yijun Wang, Lina Han, Xiaodong Sun, Honglin Yu, Yerong Yu. Clin Ther 2012
11
16

Enzymatic barriers for GI peptide and protein delivery.
J F Woodley. Crit Rev Ther Drug Carrier Syst 1994
224
16

Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial.
Shlomo Melmed, Vera Popovic, Martin Bidlingmaier, Moises Mercado, Aart Jan van der Lely, Nienke Biermasz, Marek Bolanowski, Mihail Coculescu, Jochen Schopohl, Karoly Racz,[...]. J Clin Endocrinol Metab 2015
85
16

Small-scale systems for in vivo drug delivery.
David A LaVan, Terry McGuire, Robert Langer. Nat Biotechnol 2003
564
16


Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems.
Catarina Pinto Reis, Ronald J Neufeld, António J Ribeiro, Francisco Veiga. Nanomedicine 2006
116
16


Oral lipid-based formulations.
David J Hauss. Adv Drug Deliv Rev 2007
305
16


Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT.
Er-Yuan Chuang, Giang Thi Ha Nguyen, Fang-Yi Su, Kun-Ju Lin, Chiung-Tong Chen, Fwu-Long Mi, Tzu-Chen Yen, Jyuhn-Huarng Juang, Hsing-Wen Sung. Biomaterials 2013
33
16

Improvement in clinical markers in CF patients using a reduced glutathione regimen: an uncontrolled, observational study.
Alfredo Visca, Clark T Bishop, Sterling C Hilton, Valerie M Hudson. J Cyst Fibros 2008
24
16


The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes.
S D Luzio, G Dunseath, A Lockett, T P Broke-Smith, R R New, D R Owens. Diabetes Obes Metab 2010
32
16

Reversible lipidization for the oral delivery of salmon calcitonin.
Jeff Wang, Donald Chow, Hashem Heiati, Wei-Chiang Shen. J Control Release 2003
79
16

Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
Yu-Hsin Lin, Fwu-Long Mi, Chiung-Tong Chen, Wei-Chun Chang, Shu-Fen Peng, Hsiang-Fa Liang, Hsing-Wen Sung. Biomacromolecules 2007
203
16



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.